Deciphera Pharms Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for DECIPHERA PHARMS, and what generic alternatives to DECIPHERA PHARMS drugs are available?
DECIPHERA PHARMS has one approved drug.
There are seven US patents protecting DECIPHERA PHARMS drugs.
There are forty patent family members on DECIPHERA PHARMS drugs in twelve countries.
Summary for Deciphera Pharms
| International Patents: | 40 |
| US Patents: | 7 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Deciphera Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Deciphera Pharms | QINLOCK | ripretinib | TABLET;ORAL | 213973-001 | May 15, 2020 | RX | Yes | Yes | 10,966,966 | See Plans and Pricing | See Plans and Pricing | ||||
| Deciphera Pharms | QINLOCK | ripretinib | TABLET;ORAL | 213973-001 | May 15, 2020 | RX | Yes | Yes | 8,188,113 | See Plans and Pricing | Y | Y | See Plans and Pricing | ||
| Deciphera Pharms | QINLOCK | ripretinib | TABLET;ORAL | 213973-001 | May 15, 2020 | RX | Yes | Yes | 11,185,535 | See Plans and Pricing | Y | See Plans and Pricing | |||
| Deciphera Pharms | QINLOCK | ripretinib | TABLET;ORAL | 213973-001 | May 15, 2020 | RX | Yes | Yes | 11,344,536 | See Plans and Pricing | See Plans and Pricing | ||||
| Deciphera Pharms | QINLOCK | ripretinib | TABLET;ORAL | 213973-001 | May 15, 2020 | RX | Yes | Yes | 11,266,635 | See Plans and Pricing | See Plans and Pricing | ||||
| Deciphera Pharms | QINLOCK | ripretinib | TABLET;ORAL | 213973-001 | May 15, 2020 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Deciphera Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2010503701 | See Plans and Pricing |
| Australia | 2007296450 | See Plans and Pricing |
| South Korea | 20110074633 | See Plans and Pricing |
| Eurasian Patent Organization | 026730 | See Plans and Pricing |
| China | 101553232 | See Plans and Pricing |
| Israel | 290363 | See Plans and Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
